Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Charles Astles is active.

Publication


Featured researches published by Peter Charles Astles.


Bioorganic & Medicinal Chemistry | 2001

Diamine containing VLA-4 antagonists

Peter Charles Astles; Neil Victor Harris; Andrew David Morley

Design and synthesis of a library as potential VLA-4 antagonists has been accomplished, based around a proposed pharmacophoric model. Compounds possessing submicromolar potency were identified and structure-activity relationships were seen across the library. Further derivatisation produced compounds with IC(50)s <10 nmol for inhibiting the VLA-4 mediated binding of fibronectin to RAMOS cells, providing an ideal starting point for a lead optimisation Programme.


Archive | 1997

Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase

Paul Joseph Cox; Shelley Bower; David J. Aldous; Peter Charles Astles; Daniel G. Mcgarry; Christopher Hulme; John Robinson Regan; Fu-chih Huang; Stevan Wakefield Djuric; Kevin Joseph Moriarty; Rose Mappilakunnel Mathew; Gregory Bernard Poli


Archive | 1997

Substituted azabicyclic compounds

Paul Joseph Cox; Shelley Bower; David J. Aldous; Peter Charles Astles; Daniel G. Mcgarry; Christopher Hulme; John Robinson Regan; Fu-chih Huang; Stevan Wakefield Djuric; Kevin Joseph Moriarty; Rose Mappilakunnel Mathew; Gregory Bernard Poli


Archive | 2001

Arylmethylamine derivatives for use as tryptase inhibitors

Peter Charles Astles; Paul Robert Eastwood; Olivier Houille; Julian Levell; Heinz W. Pauls; Mark Czekaj; Guyan Liang; Yong Gong; James Pribish; Kent Neuenschwander


Archive | 2001

1-Aroyl-piperidinyl benzamidines

Heinz W. Pauls; Yong Gong; Julian Levell; Peter Charles Astles; Paul Robert Eastwood


Archive | 1999

Substituted beta-alanines

Peter Charles Astles; Neil Victor Harris; Andrew David Morley


Bioorganic & Medicinal Chemistry | 2005

Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase

Julian Levell; Peter Charles Astles; Paul Robert Eastwood; Jennifer Cairns; Olivier Houille; Suzanne Aldous; Gregory H. Merriman; Brian Whiteley; James Pribish; Mark Czekaj; Guyan Liang; Sébastien Maignan; Jean-Pierre Guilloteau; Alain Dupuy; Jane Davidson; Trevor K.P. Harrison; Andrew David Morley; Simon Watson; Garry Fenton; Clive McCarthy; Joseph Romano; Rose Mappilakunnel Mathew; Darren Engers; Michael Gardyan; Keith Sides; Jennifer Kwong; Joseph Tsay; Sam Rebello; Liduo Shen; Jie Wang


Archive | 2000

Substituted β-alanines

Peter Charles Astles; Neil Victor Harris; Andrew David Morley


Archive | 2001

Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase Arylmethylamine derivatives for use as inhibitors of tryptase

Peter Charles Astles; Paul Robert Eastwood; Olivier Houille; Julian Levell; Heinz W. Pauls; Mark Czekaj; Guyan Liang; Yong Gong; James Pribish; Kent Neuenschwander


Archive | 2001

1-aroyl-piperidinyl benzamidines 1-aroyl-piperidinyl benzamidines

Heinz W. Pauls; Paul Robert Eastwood; Peter Charles Astles; Yong Gong; Julian Levell

Collaboration


Dive into the Peter Charles Astles's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge